GT

Giri Thalluru

Active Director Director DIN 02429445
DIN 02429445 First appointment Aug 2002 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since Aug 2002
Shareholding value •••• Premium profile

About Giri Thalluru

Data last updated:

Giri Thalluru is a Director at Saveera Institute Of Medical Sciences Private Limited (since 2018) and Designated Partner at Gr Dwellings Llp (since 2014). The companies operate in Healthcare, Construction and Real Estate and Construction. The largest current company by reported revenue is Saveera Institute Of Medical Sciences Private Limited at ₹113 Cr (FY 2025). Earlier, Giri Thalluru was an Additional Director at Excel Dwellings Oxigen Private Limited (2014–2015) and Director at Bollineni Eye Hospital And Research Centre Private Limited (2002–2024) and 3 more.

DIN 02429445
Primary Designation Director
Industry Healthcare
First Appointment 22 Aug 2002
Oldest Company Age 11 yrs
Largest company Saveera Institute Of Medical Sciences Private Limited · ₹113 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Sep 20182018₹113 Cr (FY 2025)Active
Gr Dwellings Llp AAC-9935
Designated Partner01 Dec 20142014Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director07 Jun 20142014Active
Director22 Aug 20022002Active
Director03 Nov 20162016₹23,600 (FY 2021)Amalgamated
Director04 Nov 20142014Active
Director27 Apr 20162016Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Navanidhi Nakshatra Estates Private Limited
Saveera Institute Of Medical Sciences Private Limited
Gr Dwellings Llp
Excel Dwellings Oxigen Private Limited
Premium access

Shareholding and investment profile for Giri Thalluru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Giri Thalluru

Giri Thalluru currently holds 2 directorships: Saveera Institute Of Medical Sciences Private Limited (Director, since 05 Sep 2018, revenue ₹113 Cr (FY 2025)); Gr Dwellings Llp (Designated Partner, since 01 Dec 2014).

Giri Thalluru was first appointed on 22 Aug 2002 as Director at Bollineni Eye Hospital And Research Centre Private Limited. The most recent appointment on record is 05 Sep 2018 at Saveera Institute Of Medical Sciences Private Limited.

Giri Thalluru held 5 earlier board appointments: Excel Dwellings Oxigen Private Limited (Additional Director, 07 Jun 2014 to 31 Dec 2015); Bollineni Eye Hospital And Research Centre Private Limited (Director, 22 Aug 2002 to 19 Jun 2024); Excel Dwellings Luxury Properties Private Limited (Director, 03 Nov 2016 to 19 Dec 2017); Excel Hyde Park Ventures Private Limited (Director, 04 Nov 2014 to 20 Dec 2014); Navanidhi Nakshatra Estates Private Limited (Director, from 27 Apr 2016).

The current boards of Giri Thalluru's companies include Bollineni Abhinay (Saveera Institute Of Medical Sciences Private Limited), Chandrakumar Boddu (Saveera Institute Of Medical Sciences Private Limited), Chandrakumar Boddu (Saveera Institute Of Medical Sciences Private Limited), Kusala Rao Chavali (Saveera Institute Of Medical Sciences Private Limited), Prameela Rani Yalamanchili (Saveera Institute Of Medical Sciences Private Limited), Rajeswara Rao Gandu (Saveera Institute Of Medical Sciences Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available